Oar Resources completes drilling at Gibraltar Halloysite-Kaolin Project

|

Published 14-APR-2021 12:16 P.M.

|

3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Halloysite is a rare derivate of kaolin, a clay mineral. It has traditionally used in ceramics and as a petroleum cracking catalyst, however it has a raft of exciting new applications in emerging industries set to only expand in the decades to come – energy storage, batteries, supercapacitors, carbon capture, and cancer therapeutics.

Those new applications have excited the market, especially given halloysite globally is in short supply, and since China recently closed a number of environmentally damaging mines.

Currently pure Halloysite sells for up to US$3,000/t, so a material discovery on this imminent drilling campaign could be a strong share price catalyst for the $66M capped Latin Resources (ASX:LRS).

LRS continues to make strong progress with the Noombenberry Halloysite Kaolin Project and has now received the majority of test work results from the project as it moves closer to establishing a resource estimate.

Interestingly, LRS’s WA project has very similar geology to Andromeda Metals' (ASX: ADN) projects in South Australia.

In September last year, ADN was just 4.5 cents, today it is circa 28 cents after being as high as 43 cents in mid March.

LRS is in a similar position to that of ADN back in September, but with a resource estimate due soon it would be hoping for similar traction.

While recent assay results would suggest MD Chris Gale's confidence in the project is justified at this stage, shareholders would also be interested to know he has other halloysite interests that are also progressing well.

Read: Latin Resources finalising results ahead of resource estimate

Gale's second halloysite interest is via Oar Resources Limited (ASX: OAR) for which he is executive chairman, and shareholders in that company will be hoping that his experience will assist in successfully developing the Gibraltar Project.

Gibraltar moves forward

Diversified mining group, OAR has advised that the latest phase of extension air-core drilling has been completed at its Gibraltar Halloysite-Kaolin Project in the Eyre Peninsula, in South Australia.

The project is located to the north and adjacent to the well-credentialled Andromeda Metals Ltd (ASX:ADN) Mt Hope Kaolin-Halloysite Project.

Oar completed approximately 1,400 metres of shallow drilling in 40 holes of wide-spaced 400 metres x 400 metres grid pattern in this latest phase of drilling.

This was completed directly adjacent and to the north of the company’s previous drilling completed in late 2020 which successfully confirmed the presence of high-grade halloysite mineralisation (20%) within a blanket of saprolitic clays.

Logging of drill cutting from holes in the most recent drilling has shown good white kaolinitic saprolite development in the southern portion of the drilling grid, adjacent to and along strike from the previous phase of drilling with the depth to basement/thickness of cover increasing to the north.

The following map shows the substantial landholding held by Oar, as well as illustrating its close proximity to Andromeda’s Mt Hope Project.

Results expected in May

Based on this logging, selective infill drilling on a 200 metres x 200 metres grid pattern has commenced in this area, to better define this material.

A total of 20 holes for an estimated additional 700 metres will be completed.

Approvals have also been received for a regional reconnaissance drilling program over the wider project area.

The program will aim to identify areas of granite basement favourable for the development of the targeted kaolinite clays.

This drilling will commence immediately following the current infill drilling program.

Composite samples from the early stages of the drilling have been dispatched to the laboratory for detailed test work, with results anticipated to be returned from May 2021.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X